The Best on Quality: Targets, Improvement, Systems. Yearbook of the International Academy for Quality, Vol. 1 (Book).

Autor: Cullen, Peter¹

Publikováno v: Service Industries Journal. Oct89, Vol. 9 Issue 4, p189-191. 3p.

Mosquito-borne disease surveillance by the European Centre for Disease Prevention and Control

Autor: Zeller, H., Marrama, L., Sudre, B., Bortel, W. Van, Warns-Petit, E.

Publikováno v: In Clinical Microbiology and Infection August 2013 19(8):693-698

International diagnostic accuracy study for the serological detection of chikungunya virus infection

Autor: Niedrig, M., Zeller, H., Schuffenecker, I., Drosten, C., Emmerich, P., Rumer, L., Donoso-Mantke, O.

Publikováno v: In Clinical Microbiology and Infection September 2009 15(9):880-884

Remote sensing based identification of environmental risk factors associated with West Nile disease in horses in Camargue, France

Autor: Leblond, A., Sandoz, A., Lefebvre, G., Zeller, H., Bicout, D.J.

Publikováno v: In Preventive Veterinary Medicine 2007 79(1):20-31

Yellow fever resurgence: An avoidable crisis?

Autor: Lindsey NP; Eliminate Yellow Fever Epidemic Risk Assessment Working Group, Geneva, Switzerland. frd3@cdc.gov.; Arboviral Diseases Branch, U.S. Centers for Disease Control and Prevention, Fort Collins, CO, USA. frd3@cdc.gov., Horton J; Eliminate Yellow Fever Epidemic Risk Assessment Working Group, Geneva, Switzerland.; Eliminate Yellow Fever Epidemics Strategy, High Impact Epidemics, WHO Health Emergencies Programme, World Health Organization, Geneva, Switzerland., Barrett ADT; Eliminate Yellow Fever Epidemic Risk Assessment Working Group, Geneva, Switzerland.; Department of Pathology and Sealy Institute for Vaccine Sciences, University of Texas Medical Branch, Galveston, TX, USA., Demanou M; Eliminate Yellow Fever Epidemic Risk Assessment Working Group, Geneva, Switzerland.; Regional Office for Africa, World Health Organization, Ouagadougou, Burkina Faso., Monath TP; Eliminate Yellow Fever Epidemic Risk Assessment Working Group, Geneva, Switzerland.; Crozet BioPharma, Lexington, MA, USA., Tomori O; Eliminate Yellow Fever Epidemic Risk Assessment Working Group, Geneva, Switzerland.; African Center for Genomics of Infectious Diseases (ACEGID), Redeemer's University, Ede, Nigeria., Van Herp M; Eliminate Yellow Fever Epidemic Risk Assessment Working Group, Geneva, Switzerland.; Médecins Sans Frontières, Brussels, Belgium., Zeller H; Eliminate Yellow Fever Epidemic Risk Assessment Working Group, Geneva, Switzerland.; Consultant, Paris, France., Fall IS; WHO Health Emergencies Programme, World Health Organization Headquarters, Geneva, Switzerland., Cibrelus L; Eliminate Yellow Fever Epidemic Risk Assessment Working Group, Geneva, Switzerland.; Eliminate Yellow Fever Epidemics Strategy, High Impact Epidemics, WHO Health Emergencies Programme, World Health Organization, Geneva, Switzerland., Erin Staples J; Eliminate Yellow Fever Epidemic Risk Assessment Working Group, Geneva, Switzerland.; Arboviral Diseases Branch, U.S. Centers for Disease Control and Prevention, Fort Collins, CO, USA.

Publikováno v: NPJ vaccines [NPJ Vaccines] 2022 Nov 02; Vol. 7 (1), pp. 137. Date of Electronic Publication: 2022 Nov 02.